pET28a-pro-sumo1
(Plasmid
#25101)
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 25101 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET28a
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5369
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsDH5alpha for plasmid purification. BL21(DE3) for protein production.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namepro-SUMO1
-
Alt nameSmall ubiquitin-related modifier 1
-
Alt nameSentrin
-
Alt nameUbiquitin-like protein SMT3C
-
SpeciesH. sapiens (human)
-
Insert Size (bp)330
-
MutationChanged Serine 2 to Alanine
-
GenBank IDU83117
-
Entrez GeneSUMO1 (a.k.a. DAP1, GMP1, OFC10, PIC1, SENP2, SMT3, SMT3C, SMT3H3, UBL1)
-
Tag
/ Fusion Protein
- His (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NcoI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer T7 forward
- 3′ sequencing primer T7 reverse (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET28a-pro-sumo1 was a gift from Guy Salvesen (Addgene plasmid # 25101 ; http://n2t.net/addgene:25101 ; RRID:Addgene_25101) -
For your References section:
Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs. Mikolajczyk J, Drag M, Bekes M, Cao JT, Ronai Z, Salvesen GS. J Biol Chem. 2007 Sep 7. 282(36):26217-24. 10.1074/jbc.M702444200 PubMed 17591783